| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |